Literature DB >> 33524290

The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.

Zain Chagla1.   

Abstract

SOURCE CITATION: Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603-15. 33301246.

Entities:  

Year:  2021        PMID： 33524290     DOI： 10.7326/ACPJ202102160-015

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


  27 in total

1.  Facemask wearing does not impact neuro-electrical brain activity.

Authors:  Ahmad Tamimi; Said Dahbour; Assma Al-Btush; Abdelkarim Al-Qudah; Amira Masri; Subhi Al-Ghanem; Malik E Juweid; Yazan Olaimat; Amer Al Qaisi; Qutada Al-Soub; Maha Naim; Ali Sawalmeh; Rund Jarrar; Tala Tarawneh; Mai Bader; Iskandar Tamimi
Journal:  Sci Rep       Date:  2022-05-31       Impact factor: 4.996

2.  Acceptance or Rejection of the COVID-19 Vaccine: A Study on Iranian People's Opinions toward the COVID-19 Vaccine.

Authors:  Amin Nakhostin-Ansari; Gregory D Zimet; Mohammad Saeid Khonji; Faezeh Aghajani; Azin Teymourzadeh; Amir Ali Rastegar Kazerooni; Pendar Pirayandeh; Reyhaneh Aghajani; Sepideh Safari; Kamand Khalaj; Amir Hossein Memari
Journal:  Vaccines (Basel)       Date:  2022-04-23

3.  Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.

Authors:  Sankar Prasad Chaki; Melissa M Kahl-McDonagh; Benjamin W Neuman; Kurt A Zuelke
Journal:  Microbiol Spectr       Date:  2022-05-31

4.  Blockchain for COVID-19: a comprehensive review.

Authors:  Het Shah; Manasi Shah; Sudeep Tanwar; Neeraj Kumar
Journal:  Pers Ubiquitous Comput       Date:  2021-08-05

Review 5.  Influenza Virus and SARS-CoV-2 Vaccines.

Authors:  Adam M Sandor; Michael S Sturdivant; Jenny P Y Ting
Journal:  J Immunol       Date:  2021-05-21       Impact factor: 5.426

6.  The Immunopathobiology of SARS-CoV-2 Infection.

Authors:  Milankumar Patel; Farah Shahjin; Jacob D Cohen; Mahmudul Hasan; Jatin Machhi; Heerak Chugh; Snigdha Singh; Srijanee Das; Tanmay A Kulkarni; Jonathan Herskovitz; Douglas D Meigs; Ramesh Chandra; Kenneth S Hettie; R Lee Mosley; Bhavesh D Kevadiya; Howard E Gendelman
Journal:  FEMS Microbiol Rev       Date:  2021-11-23       Impact factor: 16.408

Review 7.  Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update.

Authors:  Uttpal Anand; Shweta Jakhmola; Omkar Indari; Hem Chandra Jha; Zhe-Sheng Chen; Vijay Tripathi; José M Pérez de la Lastra
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

Review 8.  A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants?

Authors:  Rashed Noor
Journal:  Curr Clin Microbiol Rep       Date:  2021-07-03

Review 9.  Extra-Pulmonary Complications in SARS-CoV-2 Infection: A Comprehensive Multi Organ-System Review.

Authors:  Taylor J Louis; Ahmad Qasem; Latifa S Abdelli; Saleh A Naser
Journal:  Microorganisms       Date:  2022-01-12

Review 10.  Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19.

Authors:  Arjun Sharma; Konstantinos Kontodimas; Markus Bosmann
Journal:  Front Med (Lausanne)       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.